Nanjing-based GemPharmatech Co., Ltd, a center for laboratory animal seed resources and a specialist in mouse models, has entered into a partnership with Daxiang Biotech, a leading domestic company in the organoid-on-a-chip field. The collaboration aims to promote the technical integration of mouse models and organoids, with the goal of developing more efficient and biomimetic preclinical evaluation models. The financial details of the partnership have not been disclosed.
Combining Expertise in Mouse Models and Organoids
GemPharmatech’s expertise in mouse models, combined with Daxiangbio’s leadership in organoid-on-a-chip technology, positions the partnership to create advanced preclinical models that better mimic human biology. This integration of technologies is expected to enhance the accuracy and efficiency of preclinical drug testing and research.
Advancing Preclinical Drug Evaluation
The collaboration will focus on developing preclinical evaluation models that are not only more efficient but also more representative of human physiological conditions. This advancement is crucial for improving the translation of preclinical findings to clinical applications, ultimately leading to better drug development outcomes.-Fineline Info & Tech
